Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced that its Special Meeting of Stockholders (the "Special Meeting"), originally ...

The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss, the Allurion ...

The Allurion Program includes a swallowable gastric balloon, which is part of a broader weight-loss platform that also features virtual care and a behavior change program. With revenue of $34.75 ...

Looking ahead, Allurion Technologies expects steady revenue growth throughout 2025, with projected revenues of approximately $30 million. The company is focusing on launching innovative products, ...

Chardan notes that Allurion has announced additional data evaluating the use of its Allurion Balloon in combination with patients be treated with GLP1 therapy, which the analyst calls ...

Microcap Allurion Technologies (NYSE:ALUR) surged ~31% in after-hours trading Thursday after posting preliminary data on weight loss associated with its gastric balloon in combination with Novo ...

Second, the rapid weight loss achieved through the Allurion balloon the lifestyle modification strategies offered through the Allurion program. And the remote monitoring through the Allurion ...

This sets up well for a randomized trial anticipated later this year, which could potentially set up Allurion’s gastric balloon in combination with GLP-1’s as the new standard of care for ...

Second, the rapid weight loss achieved through the Allurion Balloon, the lifestyle modification strategies offered through the Allurion program and the remote monitoring through the Allurion ...

“With our recent financings complete, we believe we have a cash runway through becoming EBITDA positive and receiving FDA approval of the Allurion Balloon. And, as we initiate prospective ...

Second, the rapid weight loss achieved through the Allurion balloon the lifestyle modification strategies offered through the Allurion program. And the remote monitoring through the Allurion virtual ...

The study will focus on combination use of the Allurion Balloon with lower dose GLP-1s with the goal of demonstrating improved long-term tolerability and adherence to GLP-1 therapy. Previous ...